The Board of Directors of LSVT Global, Inc. is very pleased to announce the appointment of Dr. Cynthia Fox as Chief Executive Officer.
This new appointment grants Dr. Fox greatly expanded governance roles and responsibilities. She will also continue to oversee the day-to-day operations of the company.
As one of the Founders of LSVT Global, Dr. Fox has the experience and vision to lead the company as it broadens the reach of its current range of therapies and products and invests in new initiatives to grow the company.
LSVT Global develops innovative treatments that improve the speech and movement of people with Parkinson’s disease (PD) and other neurological conditions. We train speech, physical and occupational therapists around the world in these treatments so that they can positively impact the lives of their patients.